Menu
GeneBe

9-122854056-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001100588.3(RC3H2):c.3013G>A(p.Glu1005Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

RC3H2
NM_001100588.3 missense

Scores

6
4
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.27
Variant links:
Genes affected
RC3H2 (HGNC:21461): (ring finger and CCCH-type domains 2) Enables nucleic acid binding activity and ubiquitin protein ligase activity. Involved in protein polyubiquitination. Located in cell surface; intracellular membrane-bounded organelle; and membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RC3H2NM_001100588.3 linkuse as main transcriptc.3013G>A p.Glu1005Lys missense_variant 18/21 ENST00000357244.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RC3H2ENST00000357244.7 linkuse as main transcriptc.3013G>A p.Glu1005Lys missense_variant 18/215 NM_001100588.3 P1Q9HBD1-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 10, 2023The c.3013G>A (p.E1005K) alteration is located in exon 18 (coding exon 17) of the RC3H2 gene. This alteration results from a G to A substitution at nucleotide position 3013, causing the glutamic acid (E) at amino acid position 1005 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
Cadd
Pathogenic
26
Dann
Uncertain
1.0
DEOGEN2
Benign
0.080
T;T;.
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.017
T
MetaRNN
Uncertain
0.56
D;D;D
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.90
L;L;L
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-1.3
N;N;N
REVEL
Benign
0.21
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.96
P;P;D
Vest4
0.67
MutPred
0.37
Gain of MoRF binding (P = 0.0021);Gain of MoRF binding (P = 0.0021);Gain of MoRF binding (P = 0.0021);
MVP
0.52
MPC
0.78
ClinPred
0.77
D
GERP RS
6.2
Varity_R
0.25
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr9-125616335; API